The potential of PET/MRI imaging in oncology: a comment to a summary report of the First PET/MRI Workshop in Tuebingen in 2012

Comment

Johannes Czernin et al. Mol Imaging Biol. 2013 Aug.

. 2013 Aug;15(4):372-3.

doi: 10.1007/s11307-013-0642-y.

No abstract available

Comment on

Summary report of the First International Workshop on PET/MR imaging, March 19-23, 2012, Tübingen, Germany.
Bailey DL, Barthel H, Beyer T, Boellaard R, Gückel B, Hellwig D, Herzog H, Pichler BJ, Quick HH, Sabri O, Scheffler K, Schlemmer HP, Schwenzer NF, Wehrl HF. Bailey DL, et al. Mol Imaging Biol. 2013 Aug;15(4):361-71. doi: 10.1007/s11307-013-0623-1. Mol Imaging Biol. 2013. PMID: 23515982 Free PMC article.

1. Judenhofer MS, Wehrl HF, Newport DF, et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med. 2008;14:459–465. doi: 10.1038/nm1700. - DOI - PubMed
1. Hillner B, Siegel B, Liu D, et al. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol. 2008;26:2155–2161. doi: 10.1200/JCO.2007.14.5631. - DOI - PubMed
1. Jaffer F, Weissleder R. Molecular imaging in the clinical arena. JAMA. 2005;293:855–862. doi: 10.1001/jama.293.7.855. - DOI - PubMed
1. Kauppinen R, Peet A. Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approaches. Cancer Biol Ther. 2011;12:665–679. doi: 10.4161/cbt.12.8.18137. - DOI - PMC - PubMed
1. Dinan M, Curtis L, Hammill B, et al. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999–2006. JAMA: J Am Med Assoc. 2010;303:1625–1631. doi: 10.1001/jama.2010.460. - DOI - PubMed